D1 Capital Partners L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value (LXEO)

Filing Manager
D1 Capital Partners L.P.
Reporting Manager
D1 Capital Partners L.P.
Security
Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
LXEO
Shares outstanding
33.7M shares
Disclosed Ownership
979K shares
Ownership
2.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 09:58:26 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
D1 Capital Partners L.P. 2.9% 979K 0 979K /s/ Amanda Hector Amanda Hector, General Counsel and Chief Compliance Officer
Daniel Sundheim 2.9% 979K 0 979K /s/ Daniel Sundheim Daniel Sundheim, Individually